Could you be our new Race for Life sponsor? Here's just a few of the fantastic benefits you could receive: • Reach 250,000 participants in 160 cities 🏃♀️ • Connect with people at the heart of their community 👫 • Partner with the UK's most loved charity* ❤️ • Support life-saving cancer research 🔬 It only takes a minute to get in touch and kickstart the conversation with our friendly partnerships team 👉 https://cruk.ink/45PlVjX *Savanta BrandVue 2024 Report
Cancer Research UK (CRUK)
Non-profit Organizations
We're the world’s largest charity dedicated to saving lives through research.
About us
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research, influence and information. Nearly one in two of us will get cancer in our lifetime, but we’re finding new ways to outsmart it, so that more people can live longer, better lives free from the fear of cancer. We carry out scientific research to help prevent, diagnose and treat cancer and our groundbreaking work, funded almost entirely by the general public, will ensure that millions more people survive. Together we are beating cancer. Registered charity No. 1089464.
- Website
-
http://www.cancerresearchuk.org
External link for Cancer Research UK (CRUK)
- Industry
- Non-profit Organizations
- Company size
- 1,001-5,000 employees
- Headquarters
- London
- Type
- Nonprofit
- Specialties
- cancer research, fundraising, volunteering, and charity events
Locations
-
Primary
2 Redman Place
London, E20 1JQ, GB
Employees at Cancer Research UK (CRUK)
Updates
-
Cancer Research UK (CRUK) reposted this
Sigourney Bonner co-founded Black in Cancer while studying for her PhD in paediatric brain tumours at the University of Cambridge. One objective is to increase the number of Black scientists in cancer research, which has led to establishing a Black Leaders in Cancer PhD Scholarship Programme in partnership with Cancer Research UK (CRUK) and the Windsor Fellowship. One of the first students supported by the funded programme, Randy Greaves, says studying on our MRes PhD programme has given him the opportunity to realise a life-long dream.
Black scientists in Cambridge are driving change to help create a cancer research sector that better represents the wider population. Among them, an organisation co-founded by a Cambridge student to champion Black excellence in cancer research is also working to empower the Black community around the disease and break down harmful stigma and misconceptions. Black in Cancer was launched by Sigourney Bonner – with US colleague Dr Henry Henderson – while she was studying for a PhD in paediatric brain tumours at the Cancer Research UK (CRUK) Cambridge Institute, and Cambridge University. Sigourney, who is now a Postdoctoral Associate based at the CRUK Cambridge Institute, said: “Black people are still underrepresented in research while being overrepresented in cancer mortality. So, Black in Cancer is about addressing both of these challenges. We want to bring Black researchers to the fore, and at the same time create a trusted, and culturally informed source of information for people who are dealing with a diagnosis of cancer.” Since its launch in 2020, Black in Cancer – which recently moved its headquarters to Cancer Research UK Cambridge Institute – has established partnerships with universities and research organisations in the UK and the US, created a conference series, developed a mentorship programme, and helped Black researchers access around £1.5m of funding. The organisation has also worked with Cancer Research UK (CRUK) on the launch of the Black Leaders in Cancer PhD Scholarship Programme, in partnership with Cambridge University, to help develop the next generation of Black scientists in cancer research and tackle barriers to progression. Find out more about the programme: https://lnkd.in/e7v_gEV9 #ChangingTheStoryOfCancer #CambridgeUniversity #CambridgeResearch
-
UK visa fees are damaging cancer research. The cost of visas for scientists at our research institutes is set to rise by 44% in the next year – money that has to be paid by scientists, lab groups and from our charity funds. The UK’s visa regime is the most expensive in the world, with costs 17 times higher than the average for other leading research nations. This increase will discourage scientists from coming to work in the UK and take vital money away from our life-saving research. We’re calling on the new government to back research and make its #First100Days a #TurningPointForCancer, including by reviewing visa fees for scientists. Our Executive Director of Policy, Information and Communications at Cancer Research UK, Dr Ian Walker, said: “Inflation-busting increases to visa fees are putting off some of the world’s most talented scientists from coming to the UK. We need to compete for the world’s best scientists to deliver more world-class research, which will boost the economy, reduce pressure on the NHS and deliver better treatment for patients." Find out more 👉 https://cruk.ink/3WAvQqx
-
Congratulations to Michaela Macdonald from Carcinotech Ltd for winning June's round of the #ResearchIsBeautiful campaign 👩🔬 Michaela's submission captures a 3D-bioprinted living tumour, derived from donor glioblastoma tissue and we think it's fantastic! Cancer Research UK Science and Innovation are now well into their third round and are keen to receive your submissions before 25 July. Find out in the comments how you can get involved 👇 Thank you to everybody who's entered so far and congratulations once again, Michaela 💙
-
Cancer Research UK (CRUK) reposted this
Head of Media Relations, Cancer Research UK (Devolved nations & English regions). Ex-London Evening Standard journalist
I'm so proud to welcome three incredibly talented young people into Cancer Research UK (CRUK)'s communications department via a highly valued partnership I've cultivated over several years with the Taylor Bennett Foundation (TBF). (From L-R) Gabriele Osella, Amirah Adeniji and Sadaf Shafaghmotlagh are already making a hugely positive impact on our Media Volunteer Liaison, Social Media and News teams. TBF exists to give top-tier students, undergraduates and graduates from ethnically diverse backgrounds a leg-up in the comms industry, which has traditionally been underrepresented by many communities. While that's changing, much more needs to be done to ensure that organisations like CRUK are truly reflective of the populations they serve or represent. I have been blown away by the calibre of interns Gabriele, Amirah and Sadaf, who follow in the footsteps of previous TBF hot-shots we've had the privilege of working with. For any comms leaders in other organisations who've never heard of the TBF, I urge you to check them out: https://lnkd.in/eSNRhGyH
-
Young people affected by cancer treated at the Freeman Hospital in Newcastle have joined forces with us and Teenage Cancer Trust to create and launch a new website that aims to demystify how teenagers and young adults can take part in research. The website provides clear, understandable and age-appropriate information about taking part in three key areas of cancer research - clinical trials, genomics and biobanking. The project has been spearheaded by Teenage Cancer Trust Lead Nurse Karen Hamlen, and Cancer Research UK Nurse Consultant Ben Hood. Ben said: “Cancer patients that take part in clinical trials are incredible. We want to give them the tools to make an informed decision about considering taking part in research, and I believe this resource does just that. The website demystifies complex information into teenage and young adult patient-friendly language, allowing patients to make a more informed decision about taking part in clinical trials.” #CRUKYoungPeople
-
His Majesty King Charles III has announced that a bill will be introduced to to raise the age of sale for tobacco - one of the key calls of our #SmokefreeUK campaign - but what needs to happen next? Our Policy Manager, Alizée Froguel, breaks it down 👇 #KingsSpeech #InTheNews #TobaccoAndVapes
King’s Speech reintroduces legislation to raise the age of sale of tobacco
Cancer Research UK (CRUK) on LinkedIn
-
One test to detect multiple cancers – where are we now? 👇 We know that most cancers diagnosed at an earlier stage have a better prognosis. Multi-cancer tests (MCT) are liquid biopsies with the potential to support earlier detection by identifying multiple cancer types from a single sample. They detect markers of cancer in samples such as the blood, urine or saliva and can predict where in the body the cancer may be found. Currently, cancer screening programmes are available for one type of cancer at a time and use tests specific for that cancer. By researching the possibilities through robust screening trials, multi-cancer earlier detection tests (MCEDs) could revolutionise what cancer screening looks like and help us diagnose less common cancers earlier. We're keeping up to date with the latest MCT research to understand how they can diagnose cancers earlier, when they’re more curable, helping people to live longer, better lives 💙 Read part one of our multi-cancer tests series 👇 #CancerResearch #EarlyDiagnosis
One test to detect multiple cancers – where are we now?
Cancer Research UK (CRUK) on LinkedIn
-
Do-it-yourself human papillomavirus (HPV) tests could enable over one million more women in England to participate in cervical screening over the next three years. Although current cervical screening tests can prevent cervical cancer and save lives, not everyone feels able to take part. The YouScreen trial has shown that HPV self-sampling kits can give people overdue for screening an alternative option that they may find more convenient. Thanks to the trial, led by researchers at King's College London and supported by our funding, we're now one step closer to tackling health inequalities and ensuring that everyone can benefit from screening. Read more about the study 👇 #CervicalScreening #CervicalCancer #CRUKscience
HPV self-sampling could help screen one million more women for cervical cancer
Cancer Research UK (CRUK) on LinkedIn